Rating Change
Barclays analysts initiated coverage on Constellium SE (NYSE:CSTM) with a rating of Equal-Weight on October 14, 2026.
new coverageNYSE:CSTM
Barclays Initiates Coverage on Constellium SE (CSTM) with Equal-Weight
Barclays analysts initiated coverage on Constellium SE (NYSE:CSTM) with a rating of Equal-Weight on October 14, 2026.
At publication ·
What changed
Constellium SE (NYSE:CSTM) · new coverage
- Firm
- Barclays
- Rating
- Equal-Weight
- Price at event
- $25.13
- Market capitalization
- $2.6B
At a glance
Key takeaways
- Barclays initiated Equal-Weight coverage on Constellium SE on October 14, 2026, suggesting neutral near-term outlook for the stock.
- The stock has surged 78.8% over the past 52 weeks and currently trades at $25.13 with a $2.6B market capitalization.
Market Context
Constellium SE operates in the Basic Materials sector. The stock currently trades at $25.13 with a market capitalization of $2.6B. The stock has gained 78.8% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Constellium SE.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Constellium SE
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 14, 2026 | Barclays | Equal-Weight | N/A |
| Oct 08, 2026 | Deutsche Bank | Buy | N/A |
| Oct 08, 2026 | UBS | Buy | N/A |
| Sep 18, 2026 | Wells Fargo | Overweight | N/A |
| Jul 30, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View CSTM Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for CSTM?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Constellium SE (NYSE:CSTM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CSTM forecast page.